207 related articles for article (PubMed ID: 30774967)
21. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
[TBL] [Abstract][Full Text] [Related]
22. Non-cardiac Chest Pain in Japan: Prevalence, Impact, and Consultation Behavior - A Population-based Study.
Chen J; Oshima T; Kondo T; Tomita T; Fukui H; Shinzaki S; Miwa H
J Neurogastroenterol Motil; 2023 Oct; 29(4):446-454. PubMed ID: 37814435
[TBL] [Abstract][Full Text] [Related]
23. Noncardiac chest pain: evaluation and treatment.
Eslick GD; Fass R
Gastroenterol Clin North Am; 2003 Jun; 32(2):531-52. PubMed ID: 12858605
[TBL] [Abstract][Full Text] [Related]
24. Role of oesophageal manometry in clinical practice.
Gambitta P; Indriolo A; Grosso C; Pirone Z; Colombo P; Arcidiacono R
Dis Esophagus; 1999; 12(1):41-6. PubMed ID: 10941860
[TBL] [Abstract][Full Text] [Related]
25. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
[TBL] [Abstract][Full Text] [Related]
26. Non-Cardiac Chest Pain as a Persistent Physical Symptom: Psychological Distress and Workability.
Flóvenz SÓ; Salkovskis P; Svansdóttir E; Karlsson HD; Andersen K; Sigurðsson JF
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767887
[TBL] [Abstract][Full Text] [Related]
27. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study.
Eslick GD; Talley NJ
Neurogastroenterol Motil; 2008 Sep; 20(9):989-97. PubMed ID: 18466221
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distress.
Zhang L; Tu L; Chen J; Song J; Bai T; Xiang XL; Wang RY; Hou XH
World J Gastroenterol; 2017 Jan; 23(1):127-134. PubMed ID: 28104988
[TBL] [Abstract][Full Text] [Related]
30. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Kahrilas PJ; Hughes N; Howden CW
Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
[TBL] [Abstract][Full Text] [Related]
31. Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization.
Wong WM; Lam KF; Cheng C; Hui WM; Xia HH; Lai KC; Hu WH; Huang JQ; Lam CL; Chan CK; Chan AO; Lam SK; Wong BC
World J Gastroenterol; 2004 Mar; 10(5):707-12. PubMed ID: 14991943
[TBL] [Abstract][Full Text] [Related]
32. An RCT of brief cognitive therapy versus treatment as usual in patients with non-cardiac chest pain.
Mulder R; Zarifeh J; Boden J; Lacey C; Tyrer P; Tyrer H; Than M; Troughton R
Int J Cardiol; 2019 Aug; 289():6-11. PubMed ID: 30770262
[TBL] [Abstract][Full Text] [Related]
33. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.
Pandak WM; Arezo S; Everett S; Jesse R; DeCosta G; Crofts T; Gennings C; Siuta M; Zfass A
J Clin Gastroenterol; 2002 Oct; 35(4):307-14. PubMed ID: 12352293
[TBL] [Abstract][Full Text] [Related]
34. Symptoms and disease severity in gastro-oesophageal reflux disease.
Galmiche JP; Bruley des Varannes S
Scand J Gastroenterol Suppl; 1994; 201():62-8. PubMed ID: 8047826
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
Monés J
Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence of gastro-esophageal reflux disease in patients who attended the emergency room].
Tanimura T; Adachi K; Ishimura N; Kinoshita Y
Nihon Shokakibyo Gakkai Zasshi; 2008 Jan; 105(1):54-9. PubMed ID: 18176042
[TBL] [Abstract][Full Text] [Related]
38. Non-coronary chest pain does not affect long-term mortality: a prospective, observational study using a matched population control.
Nilsson S; Järemo P
BMC Fam Pract; 2016 Nov; 17(1):159. PubMed ID: 27852221
[TBL] [Abstract][Full Text] [Related]
39. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
[TBL] [Abstract][Full Text] [Related]
40. Esophageal hypersensitivity in noncardiac chest pain.
Min YW; Rhee PL
Ann N Y Acad Sci; 2016 Sep; 1380(1):27-32. PubMed ID: 27496289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
